Aktie A0M4V7 JILIN PROVINCE HUINAN CHANGLONG BIO-PHARMACY COMPANY LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Jilin Province Huinan Changlong Bio-pharmacy Company Limited

Aktien

A0M4V7

CNE100000130

8049

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:20 14.05.2024 		% 5 Tage % 1. Jan.
1,45 HKD -2,68 % Intraday Chart für Jilin Province Huinan Changlong Bio-pharmacy Company Limited -8,23 % -11,59 %
28.03. Jilin Province Huinan Changlong Bio-pharmacy Company Limited meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Jilin Province Huinan Changlong Bio-pharmacy Company Limited meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Proposes Special Dividend, to Be Payable on or Before 16 July 2024
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Approves Special Dividend, Payment Date 30 June 2023
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Declares and Proposes a Special Dividend, Payable on or Before 30 June 2023
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Approves Special Dividend, Payable on or Before 31 August 2022
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Proposes Special Dividend, Payable on or Before 31 August 2022
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
Jilin Province Huinan Changlong Bio-pharmacy Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Approves Appointment of Bai Jun Gui as an Independent Non-Executive Director, Member of the Audit and Remuneration and Nomination Committee
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Announces Special Dividend , Payable on November 18, 2021
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Proposes Special Dividend
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Announces Resignation of Gao Yong Cai as Independent Non-Executive Director
Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0M4V7 Aktie
  4. Nachrichten Jilin Province Huinan Changlong Bio-pharmacy Company Limited
  5. Andere Sprachen